Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Market Analysis by Type
1.3.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Growth Rate by Type: 2020 VS 2026
1.3.2 HIV POC
1.3.3 Clostridium difficile POC
1.3.4 HBV POC
1.3.5 Pneumonia or Streptococcus associated infections
1.3.6 Respiratory syncytial virus (RSV) POC
1.3.7 HPV POC
1.3.8 Influenza/Flu POC
1.3.9 Other Infectious Disease POC
1.4 Market by Application
1.4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application: 2020 VS 2026
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Home
1.4.5 Assisted Living Healthcare Facilities
1.4.6 Laboratories
1.4.7 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Perspective (2015-2026)
2.2 Point-of-Care Infectious Disease Diagnostics/Testing Growth Trends by Regions
2.2.1 Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Point-of-Care Infectious Disease Diagnostics/Testing Historic Market Share by Regions (2015-2020)
2.2.3 Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Regions (2021-2026)
2.3 Point-of-Care Infectious Disease Diagnostics/Testing Industry Dynamic
2.3.1 Point-of-Care Infectious Disease Diagnostics/Testing Market Trends
2.3.2 Point-of-Care Infectious Disease Diagnostics/Testing Market Drivers
2.3.3 Point-of-Care Infectious Disease Diagnostics/Testing Market Challenges
2.3.4 Point-of-Care Infectious Disease Diagnostics/Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point-of-Care Infectious Disease Diagnostics/Testing Players by Market Size
3.1.1 Global Top Point-of-Care Infectious Disease Diagnostics/Testing Players by Revenue (2015-2020)
3.1.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Players (2015-2020)
3.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Point-of-Care Infectious Disease Diagnostics/Testing Revenue
3.4 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Concentration Ratio
3.4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point-of-Care Infectious Disease Diagnostics/Testing Revenue in 2019
3.5 Key Players Point-of-Care Infectious Disease Diagnostics/Testing Area Served
3.6 Key Players Point-of-Care Infectious Disease Diagnostics/Testing Product Solution and Service
3.7 Date of Enter into Point-of-Care Infectious Disease Diagnostics/Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-Care Infectious Disease Diagnostics/Testing Breakdown Data by Type
4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Historic Market Size by Type (2015-2020)
4.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Type (2021-2026)
5 Point-of-Care Infectious Disease Diagnostics/Testing Breakdown Data by Application
5.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Historic Market Size by Application (2015-2020)
5.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2026)
6.2 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
6.3 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
6.4 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2026)
7.2 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
7.3 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
7.4 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2026)
8.2 Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
8.3 Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
8.4 Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
9 Latin America
9.1 Latin America Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2026)
9.2 Latin America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
9.3 Latin America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
9.4 Latin America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2026)
10.2 Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
10.3 Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
10.4 Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.1.4 Abbott Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020))
11.1.5 Abbott Recent Development
11.2 Thermo Fisher Scientific Inc
11.2.1 Thermo Fisher Scientific Inc Company Details
11.2.2 Thermo Fisher Scientific Inc Business Overview
11.2.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.2.4 Thermo Fisher Scientific Inc Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.2.5 Thermo Fisher Scientific Inc Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.3.4 Roche Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.3.5 Roche Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Details
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.4.4 Siemens Healthineers Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.4.5 Siemens Healthineers Recent Development
11.5 BD & Company
11.5.1 BD & Company Company Details
11.5.2 BD & Company Business Overview
11.5.3 BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.5.4 BD & Company Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.5.5 BD & Company Recent Development
11.6 Chembio Diagnostics Inc.
11.6.1 Chembio Diagnostics Inc. Company Details
11.6.2 Chembio Diagnostics Inc. Business Overview
11.6.3 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.6.4 Chembio Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.6.5 Chembio Diagnostics Inc. Recent Development
11.7 Trinity Biotech
11.7.1 Trinity Biotech Company Details
11.7.2 Trinity Biotech Business Overview
11.7.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.7.4 Trinity Biotech Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.7.5 Trinity Biotech Recent Development
11.8 Cardinal Health
11.8.1 Cardinal Health Company Details
11.8.2 Cardinal Health Business Overview
11.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.8.4 Cardinal Health Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.8.5 Cardinal Health Recent Development
11.9 Quest Diagnostics Inc.
11.9.1 Quest Diagnostics Inc. Company Details
11.9.2 Quest Diagnostics Inc. Business Overview
11.9.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.9.4 Quest Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.9.5 Quest Diagnostics Inc. Recent Development
11.10 Bio-Rad Labs Inc.
11.10.1 Bio-Rad Labs Inc. Company Details
11.10.2 Bio-Rad Labs Inc. Business Overview
11.10.3 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.10.4 Bio-Rad Labs Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.10.5 Bio-Rad Labs Inc. Recent Development
11.11 bioMérieux SA
10.11.1 bioMérieux SA Company Details
10.11.2 bioMérieux SA Business Overview
10.11.3 bioMérieux SA Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.11.4 bioMérieux SA Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.11.5 bioMérieux SA Recent Development
11.12 Sight Diagnostics Ltd.
10.12.1 Sight Diagnostics Ltd. Company Details
10.12.2 Sight Diagnostics Ltd. Business Overview
10.12.3 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.12.4 Sight Diagnostics Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.12.5 Sight Diagnostics Ltd. Recent Development
11.13 Gene POC
10.13.1 Gene POC Company Details
10.13.2 Gene POC Business Overview
10.13.3 Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.13.4 Gene POC Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.13.5 Gene POC Recent Development
11.14 Trivitron Healthcare
10.14.1 Trivitron Healthcare Company Details
10.14.2 Trivitron Healthcare Business Overview
10.14.3 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.14.4 Trivitron Healthcare Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.14.5 Trivitron Healthcare Recent Development
11.15 OJ-Bio Ltd.
10.15.1 OJ-Bio Ltd. Company Details
10.15.2 OJ-Bio Ltd. Business Overview
10.15.3 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.15.4 OJ-Bio Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.15.5 OJ-Bio Ltd. Recent Development
11.16 Ortho-Clinical Diagnostics
10.16.1 Ortho-Clinical Diagnostics Company Details
10.16.2 Ortho-Clinical Diagnostics Business Overview
10.16.3 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.16.4 Ortho-Clinical Diagnostics Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.16.5 Ortho-Clinical Diagnostics Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Key Players of HIV POC
Table 3. Key Players of Clostridium difficile POC
Table 4. Key Players of HBV POC
Table 5. Key Players of Pneumonia or Streptococcus associated infections
Table 6. Key Players of Respiratory syncytial virus (RSV) POC
Table 7. Key Players of HPV POC
Table 8. Key Players of Influenza/Flu POC
Table 9. Key Players of Other Infectious Disease POC
Table 10. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Regions (2015-2020)
Table 14. Global Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Regions (2021-2026)
Table 16. Point-of-Care Infectious Disease Diagnostics/Testing Market Market Trends
Table 17. Point-of-Care Infectious Disease Diagnostics/Testing Market Drivers
Table 18. Point-of-Care Infectious Disease Diagnostics/Testing Market Challenges
Table 19. Point-of-Care Infectious Disease Diagnostics/Testing Market Restraints
Table 20. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Players (2015-2020) (US$ Million)
Table 21. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Players (2015-2020)
Table 22. Global Top Point-of-Care Infectious Disease Diagnostics/Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-of-Care Infectious Disease Diagnostics/Testing as of 2019)
Table 23. Global Point-of-Care Infectious Disease Diagnostics/Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Point-of-Care Infectious Disease Diagnostics/Testing Product Solution and Service
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (US$ Million)
Table 28. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Type (2015-2020)
Table 29. Global Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 30. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Share by Application (2015-2020) (US$ Million)
Table 31. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Application (2015-2020)
Table 32. Global Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 33. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (US$ Million)
Table 34. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
Table 35. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (US$ Million)
Table 36. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
Table 37. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (US$ Million) (2015-2020)
Table 38. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Country (2015-2020)
Table 39. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (US$ Million)
Table 40. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
Table 41. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (US$ Million)
Table 42. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
Table 43. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (US$ Million) (2015-2020)
Table 44. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Country (2015-2020)
Table 45. Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (US$ Million)
Table 46. Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
Table 47. Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (US$ Million)
Table 48. Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
Table 49. Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Region (US$ Million) (2015-2020)
Table 50. Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Region (2015-2020)
Table 51. Latin America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (US$ Million)
Table 52. Latin America Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
Table 53. Latin America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (US$ Million)
Table 54. Latin America Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
Table 55. Latin America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (US$ Million) (2015-2020)
Table 56. Latin America Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Country (2015-2020)
Table 57. Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (US$ Million)
Table 58. Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
Table 59. Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (US$ Million)
Table 60. Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
Table 61. Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (US$ Million) (2015-2020)
Table 62. Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Country (2015-2020)
Table 63. Abbott Company Details
Table 64. Abbott Business Overview
Table 65. Abbott Point-of-Care Infectious Disease Diagnostics/Testing Product
Table 66. Abbott Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 67. Abbott Recent Development
Table 68. Thermo Fisher Scientific Inc Company Details
Table 69. Thermo Fisher Scientific Inc Business Overview
Table 70. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Product
Table 71. Thermo Fisher Scientific Inc Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 72. Thermo Fisher Scientific Inc Recent Development
Table 73. Roche Company Details
Table 74. Roche Business Overview
Table 75. Roche Point-of-Care Infectious Disease Diagnostics/Testing Product
Table 76. Roche Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 77. Roche Recent Development
Table 78. Siemens Healthineers Company Details
Table 79. Siemens Healthineers Business Overview
Table 80. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Product
Table 81. Siemens Healthineers Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 82. Siemens Healthineers Recent Development
Table 83. BD & Company Company Details
Table 84. BD & Company Business Overview
Table 85. BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Product
Table 86. BD & Company Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 87. BD & Company Recent Development
Table 88. Chembio Diagnostics Inc. Company Details
Table 89. Chembio Diagnostics Inc. Business Overview
Table 90. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Product
Table 91. Chembio Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 92. Chembio Diagnostics Inc. Recent Development
Table 93. Trinity Biotech Company Details
Table 94. Trinity Biotech Business Overview
Table 95. Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Product
Table 96. Trinity Biotech Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 97. Trinity Biotech Recent Development
Table 98. Cardinal Health Business Overview
Table 99. Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Product
Table 100. Cardinal Health Company Details
Table 101. Cardinal Health Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 102. Cardinal Health Recent Development
Table 103. Quest Diagnostics Inc. Company Details
Table 104. Quest Diagnostics Inc. Business Overview
Table 105. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Product
Table 106. Quest Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 107. Quest Diagnostics Inc. Recent Development
Table 108. Bio-Rad Labs Inc. Company Details
Table 109. Bio-Rad Labs Inc. Business Overview
Table 110. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Product
Table 111. Bio-Rad Labs Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 112. Bio-Rad Labs Inc. Recent Development
Table 113. bioMérieux SA Company Details
Table 114. bioMérieux SA Business Overview
Table 115. bioMérieux SA Point-of-Care Infectious Disease Diagnostics/Testing Product
Table 116. bioMérieux SA Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 117. bioMérieux SA Recent Development
Table 118. Sight Diagnostics Ltd. Company Details
Table 119. Sight Diagnostics Ltd. Business Overview
Table 120. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Product
Table 121. Sight Diagnostics Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 122. Sight Diagnostics Ltd. Recent Development
Table 123. Gene POC Company Details
Table 124. Gene POC Business Overview
Table 125. Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Product
Table 126. Gene POC Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 127. Gene POC Recent Development
Table 128. Trivitron Healthcare Company Details
Table 129. Trivitron Healthcare Business Overview
Table 130. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Product
Table 131. Trivitron Healthcare Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 132. Trivitron Healthcare Recent Development
Table 133. OJ-Bio Ltd. Company Details
Table 134. OJ-Bio Ltd. Business Overview
Table 135. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Product
Table 136. OJ-Bio Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 137. OJ-Bio Ltd. Recent Development
Table 138. Ortho-Clinical Diagnostics Company Details
Table 139. Ortho-Clinical Diagnostics Business Overview
Table 140. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Product
Table 141. Ortho-Clinical Diagnostics Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 142. Ortho-Clinical Diagnostics Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type: 2020 VS 2026
Figure 2. HIV POC Features
Figure 3. Clostridium difficile POC Features
Figure 4. HBV POC Features
Figure 5. Pneumonia or Streptococcus associated infections Features
Figure 6. Respiratory syncytial virus (RSV) POC Features
Figure 7. HPV POC Features
Figure 8. Influenza/Flu POC Features
Figure 9. Other Infectious Disease POC Features
Figure 10. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application: 2020 VS 2026
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Home Case Studies
Figure 14. Assisted Living Healthcare Facilities Case Studies
Figure 15. Laboratories Case Studies
Figure 16. Others Case Studies
Figure 17. Point-of-Care Infectious Disease Diagnostics/Testing Report Years Considered
Figure 18. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size (US$ Million), YoY Growth 2015-2026
Figure 19. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Regions: 2020 VS 2026
Figure 20. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Regions (2021-2026)
Figure 21. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Players in 2019
Figure 22. Global Top Point-of-Care Infectious Disease Diagnostics/Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-of-Care Infectious Disease Diagnostics/Testing as of 2019
Figure 23. The Top 10 and 5 Players Market Share by Point-of-Care Infectious Disease Diagnostics/Testing Revenue in 2019
Figure 24. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. United States Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Canada Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Germany Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. France Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. U.K. Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Italy Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Russia Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Nordic Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. China Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. South Korea Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. India Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Australia Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Rest of Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Latin America Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Mexico Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Brazil Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. Turkey Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 47. Saudi Arabia Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 48. UAE Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 49. Abbott Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 50. Thermo Fisher Scientific Inc Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 51. Roche Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 52. Siemens Healthineers Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 53. BD & Company Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 54. Chembio Diagnostics Inc. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 55. Trinity Biotech Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 56. Cardinal Health Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 57. Quest Diagnostics Inc. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 58. Bio-Rad Labs Inc. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 59. bioMérieux SA Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 60. Sig